Reported symptoms, n (%) |
Unilateral nose symptoms |
27 (13.3%) |
23 (11.3%) |
35 (12.5%) |
53 (18.9%) |
Viscous purulent rhinorrhoea |
12 (5.9%) |
1 (0.5%) |
7 (2.5%) |
13 (4.6%) |
Abundant rhinorrhoea/posterior draining |
94 (46.3%) |
38 (18.7%) |
154 (55.0%) |
66 (23.6%) |
Facial pain |
15 (7.4%) |
5 (2.5%) |
51 (18.2%) |
18 (6.4%) |
Recurrent nose bleeds |
28 (13.8%) |
17 (8.4%) |
15 (5.4%) |
12 (4.3%) |
Hypo-osmia |
57 (28.1%) |
18 (8.9%) |
94 (33.6%) |
44 (15.7%) |
Reported symptoms most days, n (%) |
Watery rhinorrhoea |
191 (94.1%) |
102 (50.2%) |
276 (98.6%) |
130 (46.4%) |
Repetitive sneezing |
192 (94.6%) |
91 (44.8%) |
275 (98.2%) |
145 (51.8%) |
Blocked nose |
171 (84.2%) |
84 (41.4%) |
243 (86.8%) |
93 (33.2%) |
Nasal pruritus |
154 (75.9%) |
76 (37.4%) |
243 (86.8%) |
115 (41.1%) |
Signs of conjunctivitis |
171 (84.2%) |
86 (42.4%) |
252 (90.0%) |
118 (42.1%) |
Symptom frequency, n (%) |
Less than 4 days per week |
19 (9.4%) |
151 (74.4%) |
23 (8.2%) |
183 (65.4%) |
More than 4 days per week |
184 (90.6%) |
50 (24.6%) |
257 (91.8%) |
90 (32.1%) |
Symptom duration, n (%) |
Less than 4 weeks |
17 (8.4%) |
156 (76.8%) |
16 (5.7%) |
175 (62.5%) |
More than 4 weeks |
186 (91.6%) |
46 (22.7%) |
264 (94.3%) |
100 (35.7%) |
Symptom impact: sleep, n (%) |
Normal |
104 (51.2%) |
174 (85.7%) |
120 (42.9%) |
227 (81.1%) |
Disturbed |
99 (48.8%) |
29 (14.3%) |
160 (57.1%) |
53 (18.9%) |
Symptom impact: social and recreational activities, n (%) |
Normal |
83 (40.9%) |
174 (85.7%) |
95 (33.9%) |
234 (83.6%) |
Disturbed |
120 (59.1%) |
27 (13.3%) |
185 (66.1%) |
46 (16.4%) |
Symptom impact: professional and/or school activities, n (%) |
Normal |
95 (46.8%) |
29 (14.3%) |
116 (41.4%) |
232 (82.9%) |
Disturbed |
108 (53.2%) |
172 (84.7%) |
163 (58.2%) |
47 (16.8%) |
Symptom impact: uncomfortable symptoms, n (%) |
Not particularly uncomfortable |
20 (9.9%) |
155 (76.4%) |
11 (3.9%) |
199 (71.1%) |
Uncomfortable |
183 (90.1%) |
48 (23.6%) |
269 (96.1%) |
81 (28.9%) |
Symptom frequency, n (%) |
Intermittent |
30 (14.8%) |
174 (85.7%) |
34 (12.1%) |
210 (75.0%) |
Persistent |
173 (85.2%) |
27 (13.3%) |
246 (87.9%) |
64 (22.9%) |
Allergy severity, n (%) |
Mild |
15 (7.4%) |
134 (66.0%) |
4 (1.4%) |
173 (61.8%) |
Moderate or severe |
188 (92.6%) |
69 (34.0%) |
276 (98.6%) |
107 (38.2%) |